{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:24:30Z","timestamp":1787156670226,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtha.2026.06.010","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:37:30Z","timestamp":1781566650000},"page":"3232-3239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma prothrombin antigenic levels across thrombotic and hemorrhagic phenotypes in triple-positive antiphospholipid patients with antiprothrombin antibodies"],"prefix":"10.1016","volume":"24","author":[{"given":"Maria Grazia","family":"Cattini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pontara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida Linda Patrizia","family":"Caforio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2064-6071","authenticated-orcid":false,"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.06.010_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bvth.2024.100041","article-title":"Understanding the structure of \u03b22-glycoprotein I: new insights and future paths for antiphospholipid syndrome","volume":"2","author":"Kumar","year":"2025","journal-title":"Blood Vessels Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0038-1654385","article-title":"Prothrombin as cofactor for circulating anticoagulant in systemic lupus erythematosus?","volume":"3","author":"Loeliger","year":"1959","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/blood.V15.2.212.212","article-title":"A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity","volume":"15","author":"Rapaport","year":"1960","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.010_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1055\/s-0038-1646476","article-title":"Lupus anticoagulant IgG are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin","volume":"66","author":"Bevers","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1182\/blood.V72.2.512.512","article-title":"Anti-prothrombin antibodies and the lupus anticoagulant","volume":"72","author":"Fleck","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.010_bib6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1055\/s-0037-1615066","article-title":"The contribution of anti-prothrombin antibodies to lupus anticoagulant activity: discrimination between functional and non-functional anti-prothrombin antibodies","volume":"79","author":"Horbach","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2018.11.003","article-title":"Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns","volume":"172","author":"Pengo","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.010_bib8","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/jth.14765","article-title":"Tetra positive thrombotic antiphospholipid syndrome: major contribution of anti-phosphatidylserine\/prothrombin antibodies to lupus anticoagulant activity","volume":"18","author":"Cattini","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/jth.15199","article-title":"Insight into the hypercoagulable state of high-risk thrombotic APS patients: contribution of a\u03b22GPI and aPS\/PT antibodies","volume":"19","author":"Pontara","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib10","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jtha.2025.03.029","article-title":"Lupus anticoagulant and antiprothrombin antibodies: embracing the future","volume":"23","author":"Pengo","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib11","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood.2023022942","article-title":"Cryo-EM structure and functional basis of prothrombin recognition by a type I antiprothrombin antiphospholipid antibody","volume":"143","author":"Kumar","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.010_bib12","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jtha.2024.07.005","article-title":"Understanding the difference between type I and type II antiprothrombin antibodies and their effect on activated protein C resistance","volume":"22","author":"Pozzi","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib13","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.jtha.2026.01.027","article-title":"In vivo targeting of open prothrombin with the monoclonal antibody POmAb results in anticoagulation without excessive bleeding","volume":"24","author":"Brake","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fmed.2018.00281","article-title":"Structure of coagulation factor II: molecular mechanism of thrombin generation and development of next-generation anticoagulants","volume":"5","author":"Chinnaraj","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtha.2026.06.010_bib15","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.010_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-0029-1225759","article-title":"Congenital prothrombin deficiency","volume":"35","author":"Lancellotti","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib17","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1055\/s-0040-1705091","article-title":"Prothrombin is responsible for the lupus cofactor phenomenon in a patient with lupus anticoagulant-hypoprothrombinemia syndrome","volume":"4","author":"Pengo","year":"2020","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2026.06.010_bib18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1055\/s-0043-1762577","article-title":"Association between severe acute respiratory syndrome coronavirus 2 infection (COVID-19) and lupus anticoagulant-hypoprothrombinemia syndrome: a case report and literature assessment","volume":"49","author":"Monti","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib19","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood.V65.6.1538.bloodjournal6561538","article-title":"Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: mechanism and management","volume":"65","author":"Bajaj","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.010_bib20","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.010_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jth.15158","article-title":"Trial of rivaroxaban in antiphospholipid syndrome (TRAPS): two-year outcomes after the study closure","volume":"19","author":"Pengo","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib22","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/bloodadvances.2019030932","article-title":"Discovery and characterization of 2 novel subpopulations of aPS\/PT antibodies in patients at high risk of thrombosis","volume":"3","author":"Chinnaraj","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.06.010_bib23","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/jth.15320","article-title":"Antiprothrombin antibodies induce platelet activation: a possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome?","volume":"19","author":"Chayoua","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jth.13947","article-title":"Thrombocytopenia in high-risk patients with antiphospholipid syndrome","volume":"16","author":"Pontara","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib25","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1177\/09612033241299619","article-title":"Rituximab in lupus anticoagulant hypoprothrombinemia syndrome: a case report","volume":"33","author":"Agnelli Giacchello","year":"2024","journal-title":"Lupus"},{"key":"10.1016\/j.jtha.2026.06.010_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0037-1614453","article-title":"dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies","volume":"81","author":"Pengo","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109474","article-title":"Assessment of thrombophilia in patients with lupus anticoagulant","volume":"254","author":"Pontara","year":"2025","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.010_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2022.08.004","article-title":"Antiphospholipid syndrome: reversal of antiphosphatidylserine\/prothrombin-induced activated protein C resistance","volume":"218","author":"Pontara","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.010_bib29","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.2025029488","article-title":"Domain and residue mapping of autoantibodies to \u03b22GPI reveals differences among antiphospholipid syndrome phenotypes","volume":"146","author":"Kumar","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.010_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.21037\/atm.2018.08.34","article-title":"Rare congenital bleeding disorders","volume":"6","author":"Franchini","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jtha.2026.06.010_bib31","first-page":"1065","article-title":"Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome","volume":"84","author":"Della Valle","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.06.010_bib32","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1538-7836.2005.01340.x","article-title":"A randomized clinical trial of high-intensity warfarin vs conventional antithrombotic therapy for prevention of recurrent thrombosis in patients with antiphospholipid syndrome (WAPS)","volume":"3","author":"Finazzi","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.010_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.741589","article-title":"A novel ELISA assay for the detection of anti-prothrombin antibodies in antiphospholipid syndrome patients at high risk of thrombosis","volume":"12","author":"Chinnaraj","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.06.010_bib34","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.cca.2020.09.025","article-title":"Antibody profiles comprising anti-phosphatidylserine\/prothrombin differently affect thrombin generation and protein C resistance in antiphospholipid antibody carriers","volume":"510","author":"Cheng","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jtha.2026.06.010_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-019-0852-7","article-title":"Clinical insights into diffuse alveolar hemorrhage in antiphospholipid syndrome","volume":"21","author":"Stoots","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jtha.2026.06.010_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaut.2018.07.001","article-title":"Catastrophic antiphospholipid syndrome: lessons from 14 cases successfully treated in a single center. A narrative report","volume":"93","author":"Ruffatti","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jtha.2026.06.010_bib37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11926-014-0424-9","article-title":"Clinical relevance of \u03b22-glycoprotein I plasma levels in antiphospholipid syndrome","volume":"16","author":"Banzato","year":"2014","journal-title":"Curr Rheumatol Rep"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:28:25Z","timestamp":1787153305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626003892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1538783626003892"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.010","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma prothrombin antigenic levels across thrombotic and hemorrhagic phenotypes in triple-positive antiphospholipid patients with antiprothrombin antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}